Harnessing Memory NK Cell to Protect Against COVID-19
Pharmacology
[키워드] adaptive
adaptive NK cell
addition
Against
Allogeneic
antiviral activity
approach
Cell
chemokine
chimeric antigen receptor
coronavirus disease
COVID-19
cytotoxicity
early stage
effective antiviral treatment
Evidence
exhibit
function
globe
HCMV
Human Cytomegalovirus
hyper inflammation
immune system
immunization
immunopathology
Immunotherapy
imperative
Infection
infections
Inflammatory cytokine
innate immune system
Interaction
lung tissue
memory
memory NK cell
MERS
natural
NK cell
NK cells
offer
pathogen-specific
Perspective
Prevalence
progression
Proinflammatory cytokine
protective role
public health crisis
residue
respiratory infection
Responder
responses
SARS-CoV-2
severe lung pathology
subset
suppresse
therapeutic potential
Treatment
vaccination
Vaccine
vaccine-induced immune response
viral infections
virus
viruses
[DOI] 10.3389/fphar.2020.01309 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.01309 PMC 바로가기 [Article Type] Pharmacology